EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors

Ece Sahin Hafizoglu, Ferhat Ekinci iD, Mustafa Sahbazlar iD, Atike Pinar Erdogan

Current Oncology · 29.09.2026 · 33 (10) · 582

DOI: 10.3390/curroncol33100582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, online erschienen am 29.09.2026. Verfasst von Ece Sahin Hafizoglu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Faculty of Medicine, Celal Bayar University, 45030 Manisa, Turkey. Hauptthemen laut MEDLINE: Breast Neoplasms, L-Lactate Dehydrogenase, Serum Albumin, Cyclin-Dependent Kinase 4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CDK4/6 inhibitors with endocrine therapy are standard first-line treatment for hormone receptor-positive, HER2-negative metastatic breast cancer, yet simple pretreatment prognostic markers are lacking. The LDH-to-albumin ratio (LAR) and the Glasgow Prognostic Score (GPS) both incorporate serum albumin and are each reported as prognostic, but have not been compared within a single cohort, and LAR has not been examined during CDK4/6 inhibitor therapy. This study evaluated both indices in this setting.

Methods

Consecutive patients (n = 139) receiving palbociclib or ribociclib plus endocrine therapy (2020–2025) were analysed retrospectively. LAR was modelled continuously on the logarithmic scale, with hazard ratios per doubling; an external cut-off (46.27) served for Kaplan–Meier illustration only. GPS was calculated in its original form. As both contain albumin, each entered a separate multivariable Cox model with identical covariates. Endpoints were overall survival (OS) and progression-free survival (PFS).

Results

Over a median follow-up of 50.0 months, 72 deaths and 110 progression events occurred. LAR was independently associated with OS (adjusted HR 2.87 per doubling, 95% CI 1.78–4.62, p < 0.001) and PFS (2.21, 1.45–3.35, p < 0.001). GPS was independently associated with OS (1.72, 1.05–2.82, p = 0.032) but not PFS (1.32, 0.88–1.98, p = 0.187). LAR-based models had lower Akaike information criterion values (ΔAIC 12.3 and 10.9), but concordance did not differ significantly between the indices (ΔC ≈ 0.04, p > 0.20).

Conclusions

Baseline LAR, an inexpensive routine index, was associated with both endpoints, whereas GPS was associated with overall survival alone. Discrimination was modest for both indices (C-index ≤ 0.61) and did not differ significantly between them. External validation is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsL-Lactate DehydrogenaseSerum AlbuminCyclin-Dependent Kinase 4Protein Kinase InhibitorsCyclin-Dependent Kinase 6HumansFemalePrognosisRetrospective StudiesMiddle AgedAgedAdultPyridinesBiomarkers, TumorNeoplasm Metastasis

Stichwörter der Autor:innen

Glasgow Prognostic Scorebreast cancercyclin-dependent kinase 4/6 inhibitorslactate dehydrogenase-to-albumin ratioprognosis

Substanzen

L-Lactate DehydrogenaseSerum AlbuminCyclin-Dependent Kinase 4Protein Kinase InhibitorsCyclin-Dependent Kinase 6PyridinesBiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Medical Oncology, Faculty of Medicine, Celal Bayar University, 45030 Manisa, Turkey.

ORCID-Profile: Ferhat Ekinci, Mustafa Sahbazlar

Zitieren

APA

Sahin Hafizoglu, E., Ekinci, F., Sahbazlar, M., & Erdogan, A. P. (2026). Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. Current Oncology, 33(10), 582. https://doi.org/10.3390/curroncol33100582

Vancouver

Sahin Hafizoglu E, Ekinci F, Sahbazlar M, Erdogan AP. Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. Current Oncology. 2026;33(10):582. doi:10.3390/curroncol33100582

BibTeX
@article{SahinHafizoglu2026,
  author = {Sahin Hafizoglu, Ece and Ekinci, Ferhat and Sahbazlar, Mustafa and Erdogan, Atike Pinar},
  title = {Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {10},
  pages = {582},
  doi = {10.3390/curroncol33100582}
}
Kostenlos starten →